F-star Therapeutics Inc logo

F-star Therapeutics Inc

$ 5.12 +0.07 (+1.39%) 10:08 PM EST
P/E:
At Loss
P/B:
1.61
Market Cap:
$ 110.51M
Enterprise V:
$ 68.89M
Volume:
113.13K
Avg Vol (2M):
144.89K
Also Trade In:
Volume:
113.13K
Market Cap $:
110.51M
PE Ratio:
At Loss
Avg Vol (2-Month):
144.89K
Enterprise Value $:
68.89M
PB Ratio:
1.61
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
F-star Therapeutics Inc is a clinical-stage biopharmaceutical company developing tetravalent bispecific antibodies for a paradigm-shift in cancer therapy. By developing medicines that seek to block tumor immune evasion, the company's goal is to offer patients greater and more durable benefits than immuno-oncology treatments.
Name Current Vs Industry Vs History
Cash-To-Debt 4.12
Equity-to-Asset 0.71
Debt-to-Equity 0.18
Debt-to-EBITDA -0.37
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0.31
Distress
Grey
Safe
Beneish M-Score 13.7
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 17.82
9-Day RSI 17.81
14-Day RSI 21.95
6-1 Month Momentum % 89.01
12-1 Month Momentum % -8.33

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 4.23
Quick Ratio 4.23
Cash Ratio 3.46
Days Sales Outstanding 49.11

Dividend & Buy Back

Name Current Vs Industry Vs History

Financials (Next Earnings Date:2022-11-10 Est.)

FSTX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:FSTX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 20.801
EPS (TTM) ($) -1.5
Beta 0
Volatility % 123.88
14-Day RSI 21.95
14-Day ATR ($) 0.243735
20-Day SMA ($) 5.9465
12-1 Month Momentum % -8.33
52-Week Range ($) 2.07 - 7.5847
Shares Outstanding (Mil) 21.58

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

F-star Therapeutics Inc Filings

Document Form Filing Date
No Filing Data

F-star Therapeutics Inc Analysis

Share your research

Headlines

See More
No news.